BPC-157: the "heal like Wolverine" peptide, honestly
BPC-157：那颗"金刚狼同款"的修复肽，真相是什么
Joe Rogan loves it. Athletes swear by it. The rat data looks miraculous. The human data barely exists — and the mechanism that heals your tendons may also feed tumors. Here's the full picture.
Joe Rogan 把它挂在嘴边，运动员发誓离不开它。老鼠实验里它简直像魔法——但真正的人体证据少得让人心虚，而那条修复肌腱的机制，也正是肿瘤用来壮大自己的那条路。先把账算清楚，再说吃不吃。
🧬 How It Works
🧬 作用机制
Four mechanisms, one theme — restore blood flow, rebuild tissue. BPC-157 is a pentadecapeptide — 15 amino acids — derived from a protein in human gastric juice. It survives stomach acid (that's why oral dosing is even on the table) and acts on four main pathways.
四条通路，一个主题——把血送进去，把组织修起来。BPC-157 是一条由 15 个氨基酸组成的肽，来源于人体胃液里一种更大的蛋白。它能抗胃酸、撑下来（这也是为什么它连口服都能考虑），进到体内后沿四条通路发力。
BPC-157 increases nitric oxide synthesis. Nitric oxide is a potent vasodilator — it opens blood vessels — and it inhibits platelet aggregation so blood doesn't clot up. More open vessels, more blood reaching injury sites, more oxygen and nutrients for repair.
BPC-157 会提升一氧化氮的合成量。一氧化氮是强效血管舒张剂——把血管打开——同时抑制血小板聚集，让血液不会在半路凝成块。管道更通畅，更多血流抵达受伤部位，更多氧气和营养送达修复现场。
BPC-157 upregulates vascular endothelial growth factor — the signal that tells the body to grow new blood vessels from existing ones. More vessels into an injury site means more repair capacity. The same mechanism, as Section 3 will show, is one of the main ways tumors grow.
上调血管内皮生长因子（VEGF）——那个"造血管"的信号蛋白，让身体从现有血管上抽枝出新的血管（医学上叫"血管新生"）。受伤的地方多长几根血管，修复能力就多几分底气。这条机制，正是第三节"要命的转折"里癌症担忧的起点——肿瘤也靠 VEGF 壮大自己。
Collagen is the structural protein in tendons, ligaments, skin, and gut lining. BPC-157 increases its production, directly supporting tissue repair — like sending extra bricks to the construction site.
胶原是肌腱、韧带、皮肤、肠道黏膜的结构主梁。BPC-157 提升胶原产量——相当于直接往修复工地运砖头。
Fibroblasts build connective tissue. BPC-157 makes them more responsive to growth hormone — effectively turning up the volume on the body's own repair signal. This is why BPC-157 shines for tendon and ligament injuries, which are notoriously slow to heal because they have poor baseline blood flow.
成纤维细胞就是负责搭建结缔组织的工人。BPC-157 让它们对生长激素更敏感——相当于把身体自己的"修复号令"音量调大。这就是为什么 BPC-157 对肌腱韧带损伤格外有意思——这些组织血流本来就少，愈合慢得出了名。
🏆 The Promise
🏆 好处在哪
Everything BPC-157 has been shown to heal — in rats. The rat data is remarkably consistent and genuinely impressive. It is also not a substitute for human data, of which there is almost none (Section 3).
下面这些，全都是 BPC-157 已被证明"有效"的领域——在老鼠身上。老鼠数据确实一致得让人印象深刻，但老鼠数据不等于人体数据。
The strongest category — the "heal like Wolverine" headline lives here. In one study, rat Achilles tendons were fully transected — cut through — and BPC-157 allowed them to heal and reattach to the bone. Another cut rat MCLs and healed them via topical, oral, and injectable administration.
证据最硬的一块，"金刚狼神话"的来源。有研究把老鼠的跟腱完全切断——是的，完全切断——给 BPC-157 之后，跟腱居然愈合、重新和骨头连回去了。另一项研究切断老鼠的内侧副韧带（MCL），局部涂、口服、注射三种给法都能让韧带长回来。
Rat quadriceps were cut and healed with BPC-157 injections. Calf-muscle crush injuries healed with both injectable and topical administration.
切断老鼠的股四头肌，BPC-157 注射之后愈合了。小腿肌肉的挤压伤，注射和局部涂用也都让它长回来。
Less studied than soft tissue. Rabbits with intentional bone defects healed when given BPC-157. The mechanism is consistent (blood flow, angiogenesis, collagen), but the evidence base is thinner.
这块研究没软组织那么多，但在兔子人为制造的骨缺损模型里，给了 BPC-157 之后也能愈合。机制讲得通（血流、血管新生、胶原），但证据薄一点。
BPC-157 is derived from gastric juice — so gut effects are where you'd expect it to work, and rodent literature confirms: inflammatory bowel disease (ulcerative colitis, Crohn's), intestinal anastomosis healing, ischemic gut injury, stomach ulcers, NSAID-induced gastric damage.
BPC-157 本来就是从胃液里提出来的，你会预期它在肠道上派上用场——啮齿动物的文献确实印证了这点：炎症性肠病（溃疡性结肠炎、克罗恩病）、肠吻合口愈合（大肠切除术后的缝合处）、缺血性肠损伤、胃溃疡、NSAID 引起的胃黏膜损伤。
Stroke model: blood supply cut off to rat brains — BPC-157 allowed full neurological recovery. TBI model: weight dropped on rat skulls — better neurological outcomes, higher survival. Nerve injury: cut sciatic nerves healed faster; spinal cord injuries recovered better.
中风模型：切断大鼠脑部供血，给 BPC-157 后居然恢复完整神经功能。外伤性脑损伤（TBI）模型：重物砸大鼠头颅，给药后恢复更好、存活率更高。神经损伤：切断的坐骨神经愈合更快，脊髓损伤也恢复更好。
Reduces schizophrenic-type symptoms in rats (probably via nitric oxide and dopamine pathways). Reduces chronic depression and chronic stress behaviors — possibly via the gut-brain axis: a less-inflamed gut means a less-inflamed brain.
减轻大鼠的类精神分裂症状（大概通过一氧化氮和多巴胺通路）。减轻慢性抑郁和慢性压力的表现——可能走的是"肠脑轴"：肠道不发炎了，大脑也跟着不那么发炎。
Postulated benefits from the nitric-oxide, anti-inflammatory, and cytoprotective mechanisms: potentially less tissue damage after heart attacks, better contractility in heart failure. Mostly speculation — this is the thinnest leg of the promise.
基于一氧化氮、抗炎、细胞保护这几个机制，推测它可能减少心梗后的组织损伤，甚至改善心衰患者的心脏收缩力。重点是"推测"——这一列是"好处清单"里证据最薄的那栏。
⚠️ The Catch
⚠️ 要命的转折
The mechanism that heals tendons is the same one cancer uses to grow. And we have almost no human data to rule that concern out.
修复肌腱的那条路，正好就是癌症赖以壮大自己的那条路。而且——几乎没有人体数据能把这个担忧排除掉。
BPC-157's greatest strength is probably also its greatest weakness.
它最大的优点，大概率也正是它最大的弱点。
A tumor, past a certain size, can't grow without new blood vessels feeding nutrients into it. Cancer solves this problem by upregulating VEGF — the same protein BPC-157 upregulates. There is a whole class of cancer drugs (bevacizumab/Avastin, ramucirumab, aflibercept, sunitinib) whose entire mechanism is inhibiting VEGF. BPC-157 does the opposite.
It also stimulates growth-hormone receptor pathways and downregulates inflammatory cascades — both of which can decrease the immune system's ability to detect and clear cancer cells. There are no studies showing BPC-157 causes or accelerates cancer in humans. There are also no long-term human studies at all. You cannot rule out what you have never measured.
肿瘤长到一定大小，没有新血管往里送营养，它就长不下去了。癌症解决这个问题的招数，就是上调 VEGF——和 BPC-157 上调的正是同一个蛋白。事实上，整整一大类抗癌药（贝伐珠单抗/Avastin、雷莫芦单抗、阿柏西普、舒尼替尼等）的使命就是——抑制 VEGF。BPC-157 做的正好相反。
它还会刺激生长激素受体通路，并下调炎症信号——两件事都可能让免疫系统识别并清除癌细胞的能力打折扣。目前没有任何研究表明 BPC-157 会在人类身上引发或加速癌症。但也完全没有长期人体研究。你无法"排除"一个从来没被测量过的风险。
12 women — interstitial cystitis, single 10 mg bladder-wall injection. Symptoms resolved. No long follow-up. (Lee et al., 2024)
2 people — IV safety pilot, 10 mg + 20 mg. Labs fine. Two doses. No long follow-up. (2025)
16 people — retrospective chart review of knee-joint injections. Pain relief reported. No safety data collected. (2021)
12 名女性——间质性膀胱炎，单次 10 mg 膀胱壁注射。症状缓解，无长期随访。（Lee 等，2024）
2 个人——静脉安全性先导试验，10 mg + 20 mg。指标正常，仅两剂，无长期随访。（2025）
16 个人——膝关节注射的回顾性病历分析。有疼痛缓解报告，未收集安全数据。（2021）
A 42-person two-week oral dosing trial (NCT02637284) was registered on clinicaltrials.gov — but results were never published. Could be benign (funding, data issues) or not. We don't know.
Earlier Phase I/II work under the name PL-14736 (same molecule, developed by Pliva for ulcerative colitis) reached humans in the early 2000s but never fully entered peer review. Whatever was collected never made it into the open literature.
一项针对 42 名健康受试者、为期两周的口服剂量试验（NCT02637284）在 clinicaltrials.gov 上登记了——但结果从未发表。原因可能很平淡（没钱、数据问题），也可能不平淡。没人知道。
更早一轮以 PL-14736 为代号的工作（同一分子，由 Pliva 公司为溃疡性结肠炎开发）在 2000 年代初也进入过人体，但同样没有完整进入同行评议的期刊。
Peptides as a class have some safety advantages — rapidly metabolized, metabolites are just amino acids, narrow sites of action. But "probably safer than a small molecule" is not the same as "proven safe." Because no long-term human trials exist, the full side-effect profile is simply not characterized.
肽类作为一大类物质，本身有几个天然的安全优势：代谢快、代谢产物就是氨基酸、作用位点狭窄。但"大概率比小分子药更安全"和"已被证明安全"不是一回事。正因为没有长期人体试验，连短期副作用的完整图谱都还没画出来。
🛑 Who Should (Not) Take It
🛑 谁不该吃
Quinn's recommendations: who should stay away, what to screen for before anyone else considers it, and the narrow window of defensible use.
Quinn 的建议：哪些人请直接绕道；其他人想尝试之前，先把哪些体检做了；以及唯一站得住脚的使用场景。
For these groups, the theoretical cancer risk outweighs any short-term benefit:
- Active cancer of any kind
- Precancerous diagnosis — polyps, abnormal biopsies
- Strong family history of cancer
对下面这几类人，理论上的癌症风险远远大于短期可能的获益。别碰就是别碰：
- 现患任何癌症
- 癌前病变——结肠息肉、异常活检等
- 有强烈癌症家族史
Even without known cancer, be up to date on age-appropriate screening. Screening isn't perfect — not every cancer is caught — which is why BPC-157 is not a "take it forever for general recovery" compound.
- Colonoscopy
- PSA + digital rectal exam (prostate)
- Mammograms
- Pelvic exams & Pap smears
- Chest CT (former smoker)
- Skin check (high-risk)
即便没有已知癌症，也先把适龄的常规筛查做全。筛查不是万能——不是每一种癌症都能查出来——这也正是 BPC-157 不适合长吃的另一个理由。
- 肠镜
- PSA + 直肠指检（前列腺）
- 乳腺钼靶
- 盆腔检查 & 宫颈涂片
- 胸部 CT（有吸烟史）
- 皮肤筛查（高风险人群）
Until human safety data exists, the only defensible use is short-term, targeted — an injury (gut or musculoskeletal) that has not healed by other means, where you've tried everything else. A 4-to-8-week course, then stop.
Not for general recovery. Not for "I want to heal faster from yesterday's workout." Not indefinitely.
在人体安全数据补齐之前，唯一说得过去的用法是：别的办法都试过了、实在好不了的那个伤——不管是肠胃的毛病还是肌腱韧带的老伤——你已经走投无路。那就来一轮 4 到 8 周。然后停。
不是为了"今天训练完明天能多恢复一点"。不是为了日常保养。不是"长期服用看看效果"。
💉 Practicalities
💉 实操指南
If you're going to take it, here's the least-bad way to do it — forms, dosing, timing, cycling.
如果你真打算吃，以下是"至少别把自己搞坏"的那套流程：剂型、剂量、时间、周期。
Four administration routes, with meaningfully different bioavailability:
四种给法，吸收差别很大。皮下注射系统吸收最高，对肌腱韧带损伤最合适。口服和肠道直接接触，胃肠问题首选。局部涂抹吸收低，只有浅表伤口才有意义。静脉注射 100% 吸收但没法日常。
The injectable form in the US is research-use-only; you cannot get it from a licensed compounding pharmacy. If you go oral, look specifically for the arginate salt form — it improves water solubility, buffers stomach acid, and is believed to improve absorption. Injection-site note: subcutaneous BPC-157 is rapidly metabolized and swept into systemic circulation, so you don't need to inject near the injury.
美国市面上的注射剂都打着"仅供研究用途"的标签——你在正规的复方药房（compounding pharmacy）根本买不到。如果走口服，请特别留意 精氨酸盐（arginate） 形式——据说能改善水溶性、缓冲胃酸、提高吸收。皮下注射不必打在伤口附近：BPC-157 代谢极快，打进皮下后很快被局部静脉带走、回到全身循环再送到伤处。
There is no correct human dose. Two reference points:
没有"正确的人用剂量"。只有两个参照系——老鼠实验外推，和民间使用经验。
From rat studies (translated):
- Common rat dose: 10 µg/kg (injectable, intraperitoneal)
- × 0.162 (allometric rat→human) → 1.62 µg/kg/day
- × 1.4 (IP→subq absorption) → 2.27 µg/kg/day subq
- For an 80 kg person: ~180 µg/day subq · ~360 µg/day oral
From anecdotal human use:
- Subcutaneous: 250–500 µg/day
- Oral: 500–1000 µg/day
从老鼠实验外推：
- 最常见的大鼠剂量：10 µg/kg（注射，腹腔内）
- × 0.162（异速标度，换算成人用等效）→ 1.62 µg/kg/天
- × 1.4（腹腔 → 皮下 的吸收修正）→ 2.27 µg/kg/天（皮下）
- 80 公斤的人：皮下 约 180 µg/天；口服 约 360 µg/天
民间使用范围：
- 皮下：250–500 µg/天
- 口服：500–1000 µg/天
Start at the low end of the anecdotal range. Two weeks. If it's working with no side effects, stay. If not, step up. Lower is safer — especially given the long-term cancer concern.
从下限开始（皮下 250 µg，或口服 500 µg），先吃两周。有效果、没副作用，就停在这里。两周没感觉、也没副作用，再往上走。能低则低——尤其是考虑到长期的癌症担忧。
— Quinn's recommended starting strategy
— Quinn 建议的起步策略
When of day: consistency is what matters. Marginal theoretical edge at night (tissue repair is slightly upregulated during sleep).
Oral: empty stomach — two hours after last meal, or right before bed.
Split dosing: once daily at low doses; split into two doses if you scale up, since BPC-157 is rapidly metabolized and steady levels matter.
哪个时辰：关键不在"哪个时辰吃"，而在"每天都在同一时间吃"。一点点理论上的加分项：晚上吃可能更好，因为组织修复在睡眠期间会被稍微上调。
口服：要空腹——上一顿饭两小时后，或者睡前。
分次：剂量低就一天一次；剂量往上走了，就分两次，因为 BPC-157 代谢很快，拆开能让血药水平更平稳。
One course: 4 to 8 weeks, or until the injury heals — whichever comes first.
Off period: another 4 to 8 weeks before considering another course.
Do not cycle on-and-off indefinitely. This is a targeted tool, not a maintenance supplement. Unlike hormonally-related peptides, BPC-157 does not require a "5-on 2-off" weekly cycle — daily dosing during the 4–8 week block is fine.
一个周期：4 到 8 周，或者直到伤好——以先发生者为准。
间隔期：再吃下一轮之前，至少停 4 到 8 周。
绝对不要无限循环地"吃一轮停一轮"。BPC-157 是"针对性工具"，不是"日常保养"。和部分激素类肽不同，不需要"上 5 天停 2 天"这种每周循环——在 4–8 周的用药期内每天打/吃就行。
🔬 Sourcing
🔬 如何购买
As of April 2026, BPC-157 is not FDA-approved and not available at US compounding pharmacies (the FDA placed it on 503A Category 2 in 2023; a re-review is in flight but has not finalized). Any injectable form is "research use only" — a label that dodges FDA jurisdiction, not a quality guarantee. If you're going forward, every batch should come with the following.
截至 2026 年 4 月，BPC-157 未获 FDA 批准，也不在美国复方药房的可售清单上（FDA 在 2023 年将它列入 503A Category 2；复议在走流程但未落地）。你能买到的注射剂都是"仅供研究用途"——这个标签是用来规避 FDA 管辖的，不是品质保证。如果你执意要买，以下这些检测证明每一批货都必须有。
Batch-specific Certificate of Analysis via HPLC or mass spectrometry confirming the vial actually contains BPC-157 at >99% purity. Gold-standard third-party lab: Janoshik Analytical.
必须有一份批次专属的检验报告（COA），通过高效液相色谱（HPLC）或质谱证明瓶子里确实是 BPC-157，且纯度大于 99%。金标准第三方实验室：Janoshik Analytical。
USP <85> bacterial endotoxin test. Floor requirement for injectables — even pure peptide plus endotoxin contamination can trigger severe immune reactions on injection.
细菌内毒素检测（USP <85>）。这对注射剂是底线——就算肽本身再纯，若有内毒素，注射后都可能引发严重免疫反应。
USP <71> sterility test — confirms no live microbes in the vial. Injection bypasses the gut's normal microbial defense; sterility cannot be skipped.
无菌检测（USP <71>）——确认瓶子里没有活微生物。注射是直接绕开胃肠防线的——无菌这一条不能省。
Not strictly required, but a reputable vendor tests for heavy metals and other contaminants. Treat it as a quality signal, not a hard requirement.
不是必检项，但靠谱的厂商会做。把它当作"这家货有多严"的加分信号，不是硬指标。
If you want maximum assurance: buy in bulk and send one of your own vials to Janoshik (or equivalent) for independent testing. The only way to confirm the COA matches what you actually received.
想真的确认 COA 和你收到的货对得上，最可靠的办法是：批量买，随机拎一瓶寄给 Janoshik（或等价实验室）自己测一次。
For oral capsules, endotoxin and sterility matter less (your gut handles small amounts of microbes). What still matters: identity and purity — that the capsule contains what the label claims, at the claimed concentration. Batch-specific COAs remain essential.
口服的话，内毒素和无菌没那么关键——你的肠胃本来就能应付少量微生物。真正要盯住的是纯度和身份——胶囊里的东西是不是标签说的那个东西，浓度对不对。批次专属的 COA 仍然不能省。
✦ Bottom Line
✦ 一句话总结
Quinn's one-paragraph summary. If you skipped the rest, read this.
Quinn 的一段话总结。如果前面都跳过了，就看这一段。
This is not a magic bullet. The rat data is impressive. The human data barely exists. The mechanism that makes BPC-157 good at healing is the same mechanism cancer uses to grow, and we have no long-term human trials to rule that out. If you have active cancer, precancer, or a strong family history — don't. For everyone else, treat it as a short-term, targeted tool for an injury that has not healed by any other means. Get cancer-screened first. Start low. Cycle off. And don't take it indefinitely.
这不是万能药。老鼠数据确实漂亮，但人体数据几乎没有。让 BPC-157 擅长修复的那条通路，也正是癌症壮大自己的那条通路，而我们没有长期人体试验能把这个风险排除。你如果有现患癌症、癌前病变、或者强烈的癌症家族史——别吃。其他人，请把它当作一个短期、针对性的工具：用在其他办法都搞不定的那个伤上。吃之前先把癌症筛查做了。从低剂量起。吃完停下。不要长期吃。
— Quinn Stillson MD
— Quinn Stillson 医生